trial

Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis

NCTId NCT03975400
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 698 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2022-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
698 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Sequential
Masking
None
Start
2020-04-22
Primary completion
2022-05-31
Eligibility
ALL

Interventions & indications

Drugs
search engine advertisement campaign

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Michael L Birnbaum, MDPrincipal Investigator

Sites

2 total
Glen Oaks, United StatesQueens, United States

Facts & assertions

4 sourced
Enrollment
698
Phase
NA
Primary Completion Date
2022-05-31
Status
COMPLETED
relationships
The graph out of here
drug
search engine advertisement campaign
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
First Episode Psychosis
indication
Schizophrenia
indication
investigator
Michael L Birnbaum, MD
person